Experiments showed that the downregulation of FOXM1 reduced the expression and function of the matrix metalloproteinase-2/9 (MMP-2/9) and vascular endothelial growth factor (VEGF), leading to the inhibition of tumor invasion, migration, and angiogenesis (Xue et al., 2012). The gene discussed is FOXM1; the disease is neoplasm.